Literature DB >> 7155850

[Functional, histological, biochemical renal modifications. Comparative study of dibekacin, gentamicin, tobramycin, netilmicin and amikacin].

G Viotte, B Olier, J P Morin, M Godin.   

Abstract

In this study, we evaluate the nephrotoxic potential of dibekacin (D) compared to gentamicin (G), tobramycin (T), amikacin (A) and netilmicin (N). The mean features of aminoglycoside nephrotoxicity are: a lysosomal membrane fragilization, a lysosomal phospholipidosis characterized by a decrease activity of sphingomyelinase, an increase lysosomal volume with both an increase of individual size and an increase number of lysosomes, a cell necrosis and renal failure. We have quantified these parameters biochemically and morphometrically. We can classify, considering doses and durations, the aminoglycosides as gentamicin greater than or equal to netilmicin greater than dibekacin = tobramycin greater than amikacin for decreasing nephrotoxic incidence.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7155850

Source DB:  PubMed          Journal:  Nouv Presse Med        ISSN: 0301-1518


  3 in total

1.  Gentamicin, netilmicin, dibekacin, and amikacin nephrotoxicity and its relationship to tubular reabsorption in rabbits.

Authors:  N Brion; J Barge; I Godefroy; F Dromer; C Dubois; A Contrepois; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

2.  Renal disposition of gentamicin, dibekacin, tobramycin, netilmicin, and amikacin in humans.

Authors:  A Contrepois; N Brion; J J Garaud; F Faurisson; F Delatour; J C Levy; J C Deybach; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

3.  In vitro comparison of aminoglycoside activities and their synergistic action with piperacillin.

Authors:  J A Hoogkamp-Korstanje
Journal:  Infection       Date:  1985 Jan-Feb       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.